Niederer Kraft Frey (NKF) advised UBS Switzerland in connection with its role as mandated lead arranger, bookrunner, agent, security agent and original lender on the financing for the acquisition of a majority stake in Kadi
Week Ending Friday – 11/09 This is our weekly inside track into the Swiss legal market! Check out the news of the week: · Homburger advised Infront Sports & Media AG in connection with the sale of its
Raluca Ungureanu (pictured left) and Laure Morel (right) have been named Country Representatives for the Association of Corporate Counsel (ACC) in Switzerland, with responsibility for the German-speaking part of the country. The two professionals will
Week Ending Friday – 04/09 This is our weekly inside track into the Swiss legal market! Check out the news of the week: · Lenz & Staehelin advised Stryker as the NYSE-listed medtech company has signed a definitive
White & Case advised E.ON SE on the issuance of green notes with a principal amount of CHF 140 million. The notes carry a nine-year term and a fixed coupon of 1.440%, and have been admitted
Fabienne-Anne Rehulka (pictured) has expanded her remit at SIX to include public affairs, taking on the title of group general counsel and head legal, compliance, regulatory & public affairs, according to an announcement by Rehulka
Legartis, a legal tech company founded in Zurich with two entities across Switzerland and Germany, has appointed Dennis G. Jansen (pictured) as general counsel and head of legal AI. Jansen takes on responsibility for the
Lenz & Staehelin advised Sika, a globally active specialty chemicals company, in connection with its placement of an inaugural hybrid capital bond (fixed rate resettable subordinated debt) with a total amount of EUR 1 billion, split
Homburger served as Swiss counsel to the Institute of International Finance (IIF) in connection with Project Agorá. Project Agorá is a public-private collaboration convened by the Bank for International Settlements (BIS) and the Institute of
Boehringer Ingelheim, a globally active human and animal pharmaceutical company with headquarters in Ingelheim (Germany), completed the acquisition of Evax, a Swiss biotech company focused on equine health. In connection with the deal, Schellenberg Wittmer
